Teaneck-based Cognizant signed a new multiyear agreement with Organon to help improve the company’s delivery of health care products and crucial medicinal supply chain management, according to a Thursday announcement from the companies.
Through the agreement, Cognizant will help scale Organon’s health care business by delivering full-stack industrial technology support for the company’s global pharmaceutical manufacturing sites in the U.K., Netherlands, Belgium and Indonesia. Additionally, by providing remote and onsite support teams to increase real-time visibility of the manufacturing process and ensure pharmaceutical development continuity, Cognizant seeks to help Organon enhance supply chain oversight, increase medicinal yields, reduce cycle times and get products to patients faster.
“Technology is an important pillar of differentiation for Organon in fulfilling our mission of becoming the world’s leading women’s health company,” Rachel Stahler, chief information officer at Organon, stated. “By partnering with Cognizant, we have teamed up with one of world’s top technology and professional services companies to advance our digital ambitions and capabilities, along with speeding access to important therapies for women everywhere.”
“Our work with Organon to align its pharmaceutical development with Industry 4.0 principles is crucial to supporting women’s health in an efficient, expedient and compliant approach,” Surya Gummadi, Cognizant’s senior vice president of global health sciences and SVP, Americas, said. “Partnerships like ours will help create new opportunities for companies to transform their businesses and deliver quality health care at scale.”
Today, Cognizant works with each of the world’s top 30 pharmaceutical companies. Its 2019 acquisition of Zenith Technologies has enabled it to become one of the only global organizations capable of providing end-to-end support for pharmaceutical manufacturing systems. Most of Organon’s manufacturing and supply program will be managed and supported by leveraging Cognizant-Zenith capabilities.